| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4237990 | Journal of Vascular and Interventional Radiology | 2013 | 7 Pages |
Abstract
Targeted transarterial sorafenib delivery is feasible and results in higher tissue drug levels than reported for systemic sorafenib therapy, without immediate histopathologic tissue toxicity. Future studies should aim to determine the utility of sorafenib chemoembolization in reducing hypoxia-induced vasculogenesis in liver tumors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Ron C. MD, Felix Y. BSE, Elizabeth M. BS, Yongchao MS, Grace MD, Ahmad BS, Richard B. PhD, Nishant MD,